IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta] (2018)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; TRAINA, FABÍOLA - FMRP
- Unidades: ICB; FMRP
- DOI: 10.1016/j.bjhh.2017.10.001
- Subjects: LEUCEMIA MIELOIDE; CÉLULAS-TRONCO; BIOMARCADORES; MEDULA ÓSSEA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2018
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 40, n. 1, p. 92-95, 2018
- Este artigo NÃO possui versão em acesso aberto
-
ABNT
CAMPOS, Paula de Melo et al. IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]. Hematology, Transfusion and Cell Therapy. Rio de Janeiro: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.bjhh.2017.10.001. Acesso em: 07 mar. 2026. , 2018 -
APA
Campos, P. de M., Machado Neto, J. A., Lorand-Metze, I. G. H., Costa, F. F., Saad, S. T. O., & Traina, F. (2018). IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]. Hematology, Transfusion and Cell Therapy. Rio de Janeiro: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.bjhh.2017.10.001 -
NLM
Campos P de M, Machado Neto JA, Lorand-Metze IGH, Costa FF, Saad STO, Traina F. IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta] [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 1): 92-95.[citado 2026 mar. 07 ] Available from: https://doi.org/10.1016/j.bjhh.2017.10.001 -
Vancouver
Campos P de M, Machado Neto JA, Lorand-Metze IGH, Costa FF, Saad STO, Traina F. IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta] [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 1): 92-95.[citado 2026 mar. 07 ] Available from: https://doi.org/10.1016/j.bjhh.2017.10.001 - De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
- Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival
- DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients
- Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
- An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- Padronização de modelo xenográfico sistêmico de leucemia linfoide aguda
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002956124.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
